Summary & Overview
CPT 11970: Permanent Implant Placement After Tissue Expander Removal
CPT code 11970 covers the surgical procedure in which a previously placed tissue expander is removed and a permanent implant is fitted. This code is relevant nationally for reconstructive and cosmetic breast procedures and other soft-tissue reconstructions where staged expansion is used. It captures a routine step in staged implant-based reconstruction and affects billing, coverage determinations, and facility resource planning.
Key payers addressed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context, how the service is typically delivered (operating room or ambulatory surgery setting), and which payers commonly cover the procedure. The publication provides benchmarks and policy-relevant information such as typical site-of-service patterns, common billing modifiers observed for surgical implant procedures, and payer coverage considerations. It also outlines where data was not provided: associated taxonomies, ICD-10 diagnoses, and related codes are not available in the input.
This summary is intended for clinicians, coding specialists, and payer policy staff seeking a national-level briefing on the role and billing considerations for CPT code 11970 in implant-based reconstructive workflows.
Billing Code Overview
CPT code 11970 describes the surgical removal of a previously placed tissue expander and the placement of a permanent implant in the patient’s body. The procedure typically follows prior reconstructive or cosmetic surgery in which a tissue expander was used to create a pocket for eventual implant placement.
-
Service type: Surgical implant placement following removal of tissue expander
-
Typical site of service: Operating room or same-day surgical suite, performed in an inpatient or outpatient hospital setting or an ambulatory surgical center
Clinical & Coding Specifications
Clinical Context
A typical patient for 11970 is an adult who previously underwent mastectomy with immediate placement of a tissue expander and now presents for replacement of the expander with a permanent implant. The patient has completed expansion sessions, has stable soft-tissue coverage, and meets oncologic and reconstructive criteria for exchange. The clinical workflow includes preoperative evaluation (history, exam, review of prior operative reports and expansion records), informed consent, preoperative marking, general anesthesia, removal of the tissue expander, inspection and management of the implant pocket (capsulotomy or capsulectomy as needed), placement of the permanent silicone or saline implant, hemostasis, layered closure, and postoperative dressing and instructions. Typical perioperative care includes antibiotic prophylaxis, pain control, and outpatient or short-stay observation. The typical site of service is an ambulatory surgery center or hospital outpatient department where reconstructive breast surgery is performed.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
11 | Normal or typical service | Use when the procedure is performed without unusual circumstances. |
22 |